Mark James Litton - Net Worth and Insider Trading

Mark James Litton Net Worth

The estimated net worth of Mark James Litton is at least $3 Million dollars as of 2026-09-11. Mark James Litton is the Chief Business Officer of Alder BioPharmaceuticals Inc and owns about 128,189 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $2 Million. Mark James Litton is also the PRESIDENT and CEO of LeonaBio Inc and owns about 59,894 shares of LeonaBio Inc (LONA) stock worth over $419,192. Details can be seen in Mark James Litton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark James Litton has not made any transactions after 2026-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark James Litton

To

Mark James Litton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark James Litton owns 3 companies in total, including LeonaBio Inc (LONA) , Alpine Immune Sciences Inc (ALPN) , and Alder BioPharmaceuticals Inc (ALDR) .

Click here to see the complete history of Mark James Litton’s form 4 insider trades.

Insider Ownership Summary of Mark James Litton

Ticker Company Transaction Date Type of Owner
LONA LeonaBio Inc 2026-03-04 Chief Operating Officer
ALPN Alpine Immune Sciences Inc 2018-08-06 See Remarks
ALDR Alder BioPharmaceuticals Inc 2018-06-01 Chief Business Officer

Mark James Litton Latest Holdings Summary

Mark James Litton currently owns a total of 2 stocks. Among these stocks, Mark James Litton owns 128,189 shares of Alder BioPharmaceuticals Inc (ALDR) as of June 1, 2018, with a value of $2 Million and a weighting of 85.24%. Mark James Litton also owns 59,894 shares of LeonaBio Inc (LONA) as of March 4, 2026, with a value of $419,192 and a weighting of 14.76%.

Latest Holdings of Mark James Litton

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDR Alder BioPharmaceuticals Inc 2018-06-01 128,189 18.88 2,420,208
LONA LeonaBio Inc 2026-03-04 59,894 7.00 419,192

Holding Weightings of Mark James Litton


Mark James Litton Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark James Litton has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 22,727 shares on June 1, 2018, which brought Mark James Litton around $405,450.

According to the SEC Form 4 filings, Mark James Litton has made a total of 8 transactions in LeonaBio Inc (LONA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in LeonaBio Inc is the sale of 5,156 shares on March 4, 2026, which brought Mark James Litton around $27,688.

Insider Trading History of Mark James Litton

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark James Litton Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Mark James Litton owns.
View ALDR Analysis

Mark James Litton Ownership Network

Ownership Network List of Mark James Litton

No Data

Ownership Network Relation of Mark James Litton

Insider Network Chart


Mark James Litton Owned Company Details

What does LeonaBio Inc do?

Who are the key executives at LeonaBio Inc?

Mark James Litton is the Chief Operating Officer of LeonaBio Inc. Other key executives at LeonaBio Inc include CHIEF MEDICAL OFFICER Martin Javier San , Vice President of Discovery Kevin Church , and General Counsel Mark Worthington .

LeonaBio Inc (LONA) Insider Trades Summary

Over the past 18 months, Mark James Litton made 3 insider transaction in LeonaBio Inc (LONA) with a net sale of 32,865. Other recent insider transactions involving LeonaBio Inc (LONA) include a net sale of 14,206 shares made by Martin Javier San , a net sale of 10,761 shares made by Kevin Church , and a net sale of 10,730 shares made by Mark Worthington .

In summary, during the past 3 months, insiders sold 0 shares of LeonaBio Inc (LONA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,339 shares of LeonaBio Inc (LONA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,339 shares.

LeonaBio Inc (LONA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

LeonaBio Inc Insider Transactions

No Available Data

Mark James Litton Mailing Address

Above is the net worth, insider trading, and ownership report for Mark James Litton. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark James Litton's mailing address is: Bothell Wa 98011.